Current Pharmaceutical Biotechnology
Title:Meet Our Editorial Board Member
Volume: 19 Issue: 11
Author(s): Giandomenico Roviello
Affiliation:
Export Options
About this article
Cite this article as:
Roviello Giandomenico , Meet Our Editorial Board Member, Current Pharmaceutical Biotechnology 2018; 19 (11) . https://dx.doi.org/10.2174/138920101911181130150143
DOI https://dx.doi.org/10.2174/138920101911181130150143 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
18
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Stem Cells-Clinical Implications for Cancer Therapy
Current Stem Cell Research & Therapy Pain Perception and Management: Where do We Stand?
Current Molecular Pharmacology Bothrops pauloensis Snake Venom Toxins: The Search for New Therapeutic Models
Current Topics in Medicinal Chemistry Anti-Epidermal Growth Factor Receptor Strategies to Enhance Radiation Action
Current Medicinal Chemistry - Anti-Cancer Agents Patent Selections
Recent Patents on Drug Delivery & Formulation Functional Foods: Salient Features and Clinical Applications
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Update on Statins: Hope for Osteoporotic Fracture Healing Treatment
Current Drug Targets Actions of Adjunctive Nutritional Antioxidants in Periodontitis and Prevalent Systemic Inflammatory Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Current Status of Epigenetics and Anticancer Drug Discovery
Anti-Cancer Agents in Medicinal Chemistry Should Adipokines be Considered in the Choice of the Treatment of Obesity-Related Health Problems?
Current Drug Targets Chemotherapy-Induced Modifications to Gastrointestinal Microflora: Evidence and Implications of Change
Current Drug Metabolism Emerging Roles for Modulation of microRNA Signatures in Cancer Chemoprevention
Current Cancer Drug Targets Probiotics in the Prevention of Urogenital Tract Infections. Mechanisms Involved
Current Women`s Health Reviews Design of New Improved Curcumin Derivatives to Multi-targets of Cancer and Inflammation
Current Drug Targets The Immunosuppressive Role of Adenosine A2A Receptors in Ischemia Reperfusion Injury and Islet Transplantation
Current Diabetes Reviews Anti-inflammatory Phytochemicals for Chemoprevention of Colon Cancer
Current Cancer Drug Targets Meet Our Editorial Board Member:
Current Cancer Drug Targets CDK-associated Cullin 1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Human Glioblastoma
Current Cancer Drug Targets Phospholipase A2 Isoforms as Novel Targets for Prevention and Treatment of Inflammatory and Oncologic Diseases
Current Drug Targets Targeting Autophagic Pathways by Plant Natural Compounds in Cancer Treatment
Current Drug Targets